The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma

被引:0
|
作者
Yilmaz, Melek Tugce [1 ]
Kahvecioglu, Alper [1 ]
Mohammadipour, Sepideh [1 ]
Cengiz, Mustafa [1 ]
Gullu, Ibrahim [2 ]
Aksoy, Sercan [2 ]
Ozyigit, Gokhan [1 ]
Yazici, Gozde [1 ]
机构
[1] Hacettepe Univ, Radiat Oncol, Ankara, Turkiye
[2] Hacettepe Univ, Med Oncol, Ankara, Turkiye
关键词
Nasopharyngeal cancer; chemoradiotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2019
引用
收藏
页码:S1365 / S1367
页数:3
相关论文
共 50 条
  • [1] Explore the Usefulness of Concurrent Chemotherapy in Stage II Nasopharyngeal Carcinoma: A Retrospective Study
    Li, Pei-Jing
    Lai, Yu-Lin
    He, Fang
    Chen, Yuan-Yuan
    Gu, Zhuo-Sheng
    Luo, Wei
    Zhang, Qun
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update
    Jin, Ting
    Zhang, Qun
    Luo, Dong-Hua
    Jiang, Feng
    Jin, Qi-Feng
    Chen, Yuan-Yuan
    Chen, Xiao-Zhong
    Mao, Wei-Min
    TRANSLATIONAL ONCOLOGY, 2020, 13 (01): : 25 - 31
  • [3] Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy for stage II nasopharyngeal carcinoma
    Chen, Jing
    Liu, Tongxin
    Sun, Quanquan
    Jin, Ting
    MEDICINE, 2020, 99 (29) : E20443
  • [4] A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II-IVa Nasopharyngeal Carcinoma
    Yang, Kaixuan
    Zhang, Qian
    Zhang, Mengxi
    Xie, Wenji
    Li, Mei
    Zeng, Lei
    Wang, Qiang
    Zhao, Jianling
    Li, Yiping
    Li, Guangjun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] The efficacy of chemotherapy in survival of stage II nasopharyngeal carcinoma
    Pan, Xin-Bin
    Li, Ling
    Qu, Song
    Chen, Long
    Liang, Shi-Xiong
    Zhu, Xiao-Dong
    ORAL ONCOLOGY, 2020, 101
  • [6] Chemotherapy use and survival in stage II nasopharyngeal carcinoma
    Pan, Xin-Bin
    Huang, Shi-Ting
    Chen, Kai-Hua
    Zhu, Xiao-Dong
    ONCOTARGET, 2017, 8 (60) : 102573 - 102580
  • [7] Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study
    Liu, Di-Han
    Zhou, Xiao-Yu
    Pan, You-Guang
    Chen, Si
    Ye, Zheng-Hao
    Chen, Gang-Dung
    CANCER MEDICINE, 2020, 9 (04): : 1287 - 1297
  • [8] Concurrent chemotherapy and radiotherapy for nasopharyngeal carcinoma
    Mizowaki, T
    Okajima, K
    Nagata, Y
    Mitsumori, M
    Nishimura, Y
    Hiraoka, M
    RADIOLOGY, 2000, 217 : 140 - 140
  • [9] MRI-Identified Multidimensional Nodal Features: Predict Survival and Concurrent Chemotherapy Benefit for Stage II Nasopharyngeal Carcinoma
    Yang, L.
    Zhang, Y.
    Yi, J.
    Wu, R.
    Li, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E306 - E306
  • [10] Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone
    Wu, Jia-Shing
    Tsai, Yu-Chen
    Jian, James Jer-Min
    Chen, Hsin-Hsuan
    Horng, Cheng-Fang
    Cheng, Skye Hung-Chun
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (09): : 2070 - 2077